Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Current Health Monitoring System Gen 2 (G2)

K-Number: K210133 · 2021-09-03

ApplicantCurrent Health
Decision Date2021-09-03
Product CodeMSX
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Current Health Monitoring System Gen 2 (G2) is a medical device manufactured by Current Health. It received FDA 510(k) clearance on 2021-09-03 under approval number K210133. The device is classified under product code MSX. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Current Health Monitoring System Gen 2 (G2)?

Current Health Monitoring System Gen 2 (G2) is a medical device that received FDA 510(k) clearance on 2021-09-03. It is manufactured by Current Health. The 510(k) number is K210133.

When was Current Health Monitoring System Gen 2 (G2) approved by the FDA?

Current Health Monitoring System Gen 2 (G2) received FDA 510(k) clearance on 2021-09-03, under approval number K210133.

What company makes Current Health Monitoring System Gen 2 (G2)?

Current Health Monitoring System Gen 2 (G2) is manufactured by Current Health.

What is the FDA product code for Current Health Monitoring System Gen 2 (G2)?

The FDA product code for Current Health Monitoring System Gen 2 (G2) is MSX.

Related Clinical Trials

NCT01143558 Searching for Persistence of Infection in Lyme Disease COMPLETED NCT06727942 Virtual Reality-Infused Treadmill Training on Aging-Related Outcomes RECRUITING NCT01174108 Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells RECRUITING NCT06940752 VINTAGE (Ventricular Intramyocardial Navigation for Tachycardia Ablation Guided by Electrograms) Using Commercial Off-The-Shelf (COTS) Catheters ENROLLING_BY_INVITATION NCT06868914 Phase I Trial of High-Density Theta Burst Stimulation (hdTBS) NOT_YET_RECRUITING NCT07092761 Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System RECRUITING

Related PubMed Literature

PMID: 41879133 Medical Device Regulation - Who Does the FDA Serve? The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (2026) PMID: 41693672 Continuous Glucose Monitoring in Diabetes Care in Saudi Arabia: Addressing Performance Standards and Regulatory Gaps-Literature Review and Consensus Report. Journal of diabetes science and technology (2026) PMID: 41450770 Is the current regulatory framework for direct-to-consumer microbiome-based tests sufficient to protect consumers from medical, economic, and dignitary harms? Journal of law and the biosciences (2025) PMID: 40388896 Accuracy and Safety of a Continuous Noninvasive Blood Pressure Monitor in Neonates. Neonatology (2025)

Related Devices (Code: MSX)

K153156eCareManager 4.0.1Visicu, Inc. K160862AirStrip RPMAirstrip Technologies, Inc. K161164CareEvent inclusive of the CareEvent Mobile Application accessoryPhilips Medical Systems K171322eCareManager 4.1Visicu, Inc. K162607BeneVision Central Monitoring SystemShenzhen Mindray Bio-Medical Electronics Co., Ltd. K180430Digistat Smart CentralAscom Ums Srl Unipersonale

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑